Relationship between the number of drugs used during percutaneous coronary intervention and adverse events in patients with chronic coronary syndrome: Analysis of CLIDAS database
This study showed that an increase in the number of drugs used for CCS may be associated with MACE and all-cause mortality. In patients with CCS, it might be beneficial to minimize the number of medications as much as possible, while managing comorbidities and using guideline-recommended drugs.
Authors
- Takahide Kohro
- Hideo Fujita (ORCID: https://orcid.org/0000-0002-4901-3502)
- Hisaki Makimoto (ORCID: https://orcid.org/0000-0002-5302-2874)
- Tomoyuki Kabutoya (ORCID: https://orcid.org/0000-0002-5439-4303)
- Masanari Kuwabara (ORCID: https://orcid.org/0000-0002-6601-4347)
- Yasuhiro Hitomi
- Masaaki Nakayama (ORCID: https://orcid.org/0000-0002-6052-6202)
- Yusuke Oba
- Yoshihiro Miyamoto (ORCID: https://orcid.org/0000-0002-1337-0508)
- Naoyuki Akashi (ORCID: https://orcid.org/0000-0002-8603-2630)
- Tetsuya Matoba (ORCID: https://orcid.org/0000-0003-4563-304X)
- Yasushi Imai
- Eiichi Shiraki
- Arihiro Kiyosue
- Kenichi Tsujita
- Kazuomi Kario
- Ryozo Nagai (ORCID: https://orcid.org/0000-0002-0911-7868)
Institutions
- Toho University (JP)
- Kyushu University (JP)
- Jichi Medical University (JP)
- Tohoku University (JP)
- National Cerebral and Cardiovascular Center (JP)
- Jichi Medical University Hospital (JP)
- Jichi Medical University Saitama Medical Center (JP)
- The University of Tokyo (JP)
- Kumamoto University (JP)
Publication Details
- Journal
- IJC Heart & Vasculature
- Published
- 2024-09-13
- DOI
- https://doi.org/10.1016/j.ijcha.2024.101507
- Citations
- 1
- Primary Topic
- Cardiac, Anesthesia and Surgical Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.40
Funders
- Kowa Company
- Ministry of Health, Labour and Welfare